Iceland vs New Zealand: Cause of death, by non-communicable diseases, female
Iceland
91.3%
in 2021
New Zealand
90.2%
in 2021
Iceland rank
3rd
New Zealand rank
5th
Cause of death, by non-communicable diseases, female over time
- Iceland
- New Zealand
How they compare
Iceland currently reports 91.3% against 90.2% in New Zealand, a difference of 1.1%.
The two have swapped places 1 time across 6 shared years of data; in 2000 it was New Zealand ahead.
Iceland ranks 3rd and New Zealand ranks 5th of 185 countries.
Across the 3 decades both report, Iceland averaged higher in 1 and New Zealand in 2.
Head to head by decade
| Decade | Iceland | New Zealand | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 89.2% | 93.3% | 4.1% | New Zealand |
| 2010s | 90.4% | 90.8% | 0.4% | New Zealand |
| 2020s | 90.6% | 90.2% | 0.3% | Iceland |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, female, Iceland or New Zealand?
- Iceland, at 91.3% against 90.2% in New Zealand as of 2021.
- What is the difference in cause of death, by non-communicable diseases, female between Iceland and New Zealand?
- 1.1%, with Iceland ahead.
- How many years of comparable data are there for Iceland and New Zealand?
- 6 years are reported by both, from 2000 to 2021.
- How do Iceland and New Zealand rank globally for cause of death, by non-communicable diseases, female?
- Iceland ranks 3rd and New Zealand ranks 5th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, female (% of total female deaths). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of female deaths due to non-communicable diseases divided by number of all female deaths, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.